Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>A medical technology Company focused on the durable healing of wounds and the prevention of amputations announces its trading update for the six months ended 30 June 2025 as well as an update to FY 2025 guidance.</li>
<li>The Company expects to report revenue for the Period of not less than $31m (H1 2024: $26.3m), representing growth of not less than 18% (H1 2024: 26.4%).</li>
<li>In the first three months of the Period, the Company recorded revenue growth of approximately 26%. </li>
</ul>


A medical technology Company focused on the durable healing of wounds and the prevention of amputations announces its trading update for the six months ended 30 June 2025 as well as an update to FY 2025 guidance.
The Company expects to report revenue for the Period of not less than $31m (H1 2024: $26.3m), representing growth of not less than 18% (H1 2024: 26.4%).
In the first three months of the Period, the Company recorded revenue growth of approximately 26%. 


Artemis Resources

Hybridan Small Cap Feast: 21/07/2025